Harmony Biosciences Holdings, Inc. (HRMY) › Operating IncomeHarmony Biosciences Holdings, Inc. (HRMY) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$145.90M2020: $16.99M2021: $87.53M2022: $120.19M2023: $192.03M2024: $190.83M2025: $208.47M$208.47M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$208.47M+9.2%2024$190.83M-0.6%2023$192.03M+59.8%2022$120.19M+37.3%2021$87.53M+415.3%2020$16.99M+111.6%2019-$145.90M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share